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Abstract
The goal was to identify HLA-DQ8-bound b cell epitopes important in the T cell response in
autoimmune diabetes. We ﬁrst identiﬁed HLA-DQ8 (DQA1*0301/DQB1*0302) b cell epitopes using
a computational approach and then related their identiﬁcation to CD4 T cell responses. The
computational program (TEA-DQ8) was adapted from one previously developed for identifying
peptides bound to the I-A
g7 molecule and based on a library of naturally processed peptides bound to
HLA-DQ8 molecules of antigen-presenting cells. We then examined experimentally the response of
NOD.DQ8 mice immunized with peptides derived from the Zinc transporter 8 protein. Log-of-odds
scores on peptides were experimentally validated as an indicator of peptide binding to HLA-DQ8
molecules. We also examined previously published data on diabetic autoantigens, including glutamic
acid decarboxylase-65, insulin and insulinoma-associated antigen-2, all tested in NOD.DQ8
transgenic mice. In all examples, many peptides identiﬁed with a favorable binding motif generated an
autoimmune T cell response, but importantly many did not. Moreover, some peptides with weak-
binding motifs were immunogenic. These results indicate the beneﬁts and limitations in predicting
autoimmune T cell responses strictly from MHC-binding data. TEA-DQ8 performed signiﬁcantly better
than other prediction programs
Introduction
The expression of the class II MHC molecule HLA-DQ8
(DQA1*0301/DQB1*0302) is linked to susceptibility to auto-
immune diabetes mellitus (1, 2). Similar linkage to the murine
I-A
g7 molecules is found in the autoimmune strain NOD that
develops spontaneous diabetes (3). Both HLA-DQ8 (referred
to as DQ8) and I-A
g7 molecules by lacking an aspartic acid
at b57 fail to form an ion pair with an arginine at a76. This
absence of b57Asp is correlated with susceptibility to type 1
diabetes mellitus (T1DM) (4, 5). The absence of b57Asp
deﬁnes the P9 anchoring sites of DQ8 and I-A
g7 molecules
during protein processing by antigen-presenting cells (APC)
(6–11).
Peptide bound to class II MHC molecules can be identi-
ﬁed by biochemical analysis of eluates. These analyses have
been invaluable in identifying sequence motifs responsible
for peptide selection during processing. Indeed, an exten-
sive analysis of the peptides selected by cell lines express-
ing either I-Ag7 or HLA-DQ8 molecules indicated a high
level of peptides having one or several acidic residues at
the carboxyl terminus (10, 12–14). However, the identiﬁca-
tion of the b cell-MHC peptidome is difﬁcult since antigens
responsible for the autoimmune reaction are not directly pre-
sented, but only after transferred to an APC. Moreover, the
number of islet class II bearing cells is highly limited. In this
situation, computational programs that identify the peptides
could be highly useful. There have been few attempts to
build a computational model to predict DQ8-restricted T cell
epitopes (15–17). These programs identiﬁed a general pref-
erence for acidic residues at P9 but varied concerning the
other MHC anchor residues, perhaps reﬂecting the limited
databases on which they were based. Currently, two compu-
tational programs are publicly available for predicting pepti-
des bound to DQ8 molecules: RankPep and MHC2Pred
(18–20). RankPep derived a weight matrix proﬁle using
DQ8-bound peptides (18) from the MHCPEP database (21).
MHC2Pred (20) applied a matrix optimization technique,
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and JenPep databases (22, 23), and employed a support
vector machine approach to distinguish the DQ8 peptide
binders from the non-binders (19).
An effective computational program was previously devel-
oped to predict the I-A
g7 peptidome based on a large data
of natural peptides isolated from APC lines (24). Using the
previously developed program as a template, this study
reports on T cell Epitope Analyzer-DQ8 (TEA-DQ8), a pro-
gram also based on naturally sequenced peptides but mod-
iﬁed to the features of the DQ8 peptidome. TEA-DQ8 offers
an effective approach to predict the DQ8 b cell peptidome
and its relationship to the CD4 T cell response.
Research design and methods
TEA-DQ8
The TEA-DQ8 system was built on a program, described in
Chang et al. (24) and detailed in the Supplementary data
(available at International Immunology Online). In brief, the
program applied a model of 100 parameters representing
the 20 amino acids at the ﬁve MHC-binding pockets, P1,
P4, P6, P7 and P9. The features of the model were derived
from the DQ8 peptidome by iterating through an expectation–
maximization (EM) algorithm. Based on this model, the struc-
tural and statistical hindering residues were deﬁned and by
treating the proteome as the baseline, log-of-odds (LOD)
scores were used to indicate potential peptides bound to
DQ8 molecules. The data of the DQ8 peptidome came from
a previous study by Suri et al. (14): the naturally processed
peptides bound to DQ8 molecules were extracted from puri-
ﬁed molecules isolated from cell lines expressing DQ8 and
examined by tandem mass spectrometry. There were 108
peptide families, each consisting of a nine amino acid core
sequence but ﬂanked with various amino- and carboxyl-
terminal extensions (14). The 108 peptides examined had
an average length of 15 residues. Out of each family, one
peptide was selected to be representative, having the core
segment and the longest amino- and carboxyl ﬂanks.
For developing the computational program, the LOD
scores with the Laplace plus-one pseudo-counts were ap-
plied to scale each residue in terms of DQ8 preferences.
The LOD scores were generated based on the EM alignment
results: positive LOD scores indicate bias toward DQ8 and
negative LOD scores indicate bias toward the baseline pro-
teome. For example, the acidic residues favored at the P9
pocket of DQ8 were weighed positively and the hindering
residues or unfavorable residues, such as lysine and argi-
nine at P4, P6 and P9, were weighed negatively. Further-
more, bulky residues such as phenylalanine and tryptophan,
which can be accommodated by the deep P4 pocket of
DQ8, were positively weighed (Fig. 1). The acidic residues
were weakly favored at the carboxyl terminus of the peptide
at P10 and P11 (Fig. 1).
Important was the use of hindering residues introduced in
our prior computational study (24) and which reﬁned the
prediction by adding a penalty for each unfavorable residue.
The computational hindering residues were deﬁned by either
a statistical or a structural approach. A statistical hindering
residue is an amino acid that occurs well below what is
expected in random assignations. For DQ8, the statistical
hindering residues are glycine at P6, alanine, leucine and
serine at P9 (Fig. 1). A structural hindering residue is an
amino acid whose size is larger than the pocket’s size, which
is estimated by the size of the largest favored residues at
that position. For DQ8, the structural hindering residues are
tryptophan at P1, P7 and P9 as well as phenylalanine, lysine,
arginine and tyrosine at P9 (Fig. 1).
Some of the data are displayed by WebLogo (25) (http://
weblogo.berkeley.edu/), a web interface of sequence logos
program (26). It displays the level of conservation at speciﬁc
positions by the height of the residues. Each residue is
sorted according to their frequency at each position.
Peptide-binding assays
The binding assays were done on soluble DQ8 proteins pro-
duced by the recombinant baculovirus system. The assays
were performed under acidic (pH 5.5) conditions as in Suri
et al. (14). The I
125-radiolabeled hemagglutinin reference
peptide (FESTGNLIAPEYGFKISY) was incubated at 37 C for
48 h with increasing doses of unlabeled peptides in 20 mM
2-(N-morpholino)ethanesulfonic acid and 150 mM sodium
chloride. Complexes were puriﬁed from free peptide by gel
ﬁltration Bio-spin columns (Bio-Rad). The percentage of
bound peptide was evaluated by gamma counting. The con-
centration of unlabeled peptide required for 50% inhibition of
labeled peptide binding is reported (IC50). The peptides
were synthesized using ﬂuorenylmethoxycarbonyl chemistry
on a Symphony Multiplex peptide synthesizer (Protein Tech-
nologies, Tucson, AZ, USA), puriﬁed to homogeneity by C18
reverse-phase high-performance liquid chromatography and
veriﬁed by matrix-assisted laser desorption ionization time-
of-ﬂight mass spectrometry.
Enzyme-linked immunosorbent spot assays
IL-2 enzyme-linked immunosorbent spot (ELISPOT) assays
were performed on the popliteal lymph nodes of the
NOD.DQ8 transgenic mice. The mice were a generous gift
from Dr C. S. David (Mayo Clinic, Rochester, MN, USA) and
all the mice were used according to the protocols deﬁned by
the Division of Comparative Medicine, Washington University
School of Medicine. The mice were immunized in the hind
footpads with 10 nmol of Zinc transporter 8 (ZnT8) peptides
(27) in a total volume of 100 ll( 5 0ll per footpad) of com-
plete Freund’s adjuvant. IL-2 capture antibody was coated
onto the 96-well polyvinylidene ﬂuoride membrane plates
(Millipore, Bedford, MA, USA) 6 days after immunization. The
IL-2 ELISPOT antibody was diluted and set up according to
the manufacturer’s direction (BD Biosciences, San Jose, CA,
USA). One week after immunization, the mice were sacriﬁced
and the draining lymph nodes were harvested. Single-cell
suspensions were added to wells in triplicate (5 3 10
5 cells
per well) and incubated at 37 Ci n5 %C O 2 for 24 h with 10
lM ZNT8 peptide in a volume of 200 ll. The IL-2-
secreting cells were detected by a secondary anti-IL-2 mAb
and the spots of the IL-2-secreting cells were determined by
ImmunoSpot 3.2 software.
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Alignment of DQ8 peptides
The TEA-DQ8 program, which is explained in the Supple-
mentary data (available at International Immunology Online),
was based on a previous study on peptides bound to I-A
g7
proteins (24). The information for the EM alignment of the
DQ8-bound peptides came from the study of Suri et al.
(14). The alignment conﬁrmed the binding motif deduced in
that study of 108 peptides and in the crystallographic
reports (6, 7, 11) (Fig. 1A). It indicates a strong preference
for acidic residues at P9, a preference for acidic residues at
P1, for small residues at P4, P6 and P7 (alanine and serine)
and for proline and valine at P6.
The EM alignment of the I-A
g7-bound peptides was used
for comparison. (One hundred and ninety-two peptides were
examined with an average length of 17 residues (10, 24).)
Similar to the DQ8-bound peptides, the I-A
g7-bound pepti-
des strongly favor acidic residues at P9 and small residues
at P6 (alanine and serine). However, instead of small-sized
residues, the I-A
g7-bound peptides prefer medium-sized hy-
drophobic residues at P4 (leucine, isoleucine and valine).
The P7 pocket of I-A
g7 displays a special preference for
bulky residues (phenylalanine and tyrosine), which was not
found in DQ8. In addition, unlike the DQ8-bound peptides,
the I-A
g7-bound peptides show no preference for acidic resi-
dues at P1. Another difference between DQ8 and I-A
g7 is the
presence of proline found in DQ8 at P6 but rare in the MHC-
binding pockets of I-A
g7 (Fig. 1B).
Testing the program on the ZnT8 response
To predict the DQ8-restricted T cell epitopes of a protein,
TEA-DQ8 followed the procedure in Chang et al. (24). A slid-
ing window whose size was nine amino acids long traversed
the peptide segments to determine the LOD scores based
on the MHC-binding pockets; that is the cumulative LOD
scores at P1, P4, P6, P7 and P9. The predicted value was
treated as an indicator for the potential MHC-binding and
T cell epitopes. The LOD values were reﬁned with analysis
of the hindering residues and then were sorted to rank the
peptide segments as the potential MHC-binding epitopes.
To demonstrate that the LOD scores can distinguish the
binding properties of a peptide, an experiment was
designed with the ZnT8 protein, recently identiﬁed as a dia-
betic autoantigen (27). Each peptide segment was assigned
an LOD score and sorted into two groups: one having the
top ﬁve values and the other group having the lowest of the
top 30 sorted values (Supplementary Table 1, available at
International Immunology Online). Those with high LOD
scores were expected to be good binders, while those with
low LOD scores were expected to be weak binders. Four
peptides were chosen from each group to measure the bind-
ing afﬁnity. The binding experiment shows that the group
with high LOD scores binds DQ8 molecules better than
those with low LOD scores (Table 1). (As in the previous
study with I-A
g7, a strict relationship between LOD score
and IC50 value was not found.) Each of the peptides was
then tested by immunizing NOD.DQ8 mice with them. Only
peptides 166–179 induced a robust response when exam-
ined in ELISPOT assays (Fig. 2). Table 1 also shows that the
two public programs performed considerably less well.
Epitope prediction and T cell responses
Several epitopes from b cell proteins have been identiﬁed in
DQ8 transgenic mice and also in human patients. In none of
these studies was the relationship established between the
T cell responses and the MHC-binding interactions with the
DQ8 molecule; that is whether the core segments of the anti-
genic peptides contained a favorable or unfavorable MHC-
binding sequence. We examined the published information
applying the computational program for predicting the DQ8-
binding segment (28–44) (Supplementary Table 2, available
at International Immunology Online). We selected to evaluate
three proteins, glutamic acid decarboxylase-65 (GAD65),
protein tyrosine phosphatase insulinoma-associated antigen-2
(IA-2) and pre-proinsulin, in which NOD.DQ8 mice had been
immunized with the protein or with peptides derived from it
and then the T cell response was tested.
Human GAD65. The TEA-DQ8 scan of the entire GAD65
protein with the ranking of the 9-mer peptide segments are
shown in Table 2. This scan was then compared with the
results published by Herman et al. (28) and Liu et al. (29).
Both reports tested by immunizing with the GAD65 protein
and then checking the T cell response to overlapping pepti-
des of 15 (28) or 20 (29) amino acids.
The study of Herman et al. (28) from McDevitt’s laboratory
is the most useful for examining and evaluating the predic-
tion program because it included testing truncated peptides
to identify the binding segments (Tables 2). In their study,
only six epitopes were identiﬁed. In the study by Liu et al.
(29) from Elliot’s laboratory, only four epitopes elicited T cell
responses, two of which were also found in the Herman
et al. report.
Three results emerged from these evaluations: (i) out of
the eight peptide segments known to induce a response,
six were predicted by our program in the top 25 (ranked 4,
13, 14, 19, 22 and 25); (ii) some segments predicted to bind
well and which showed an excellent sequence motif did not
induce T cell responses—note the ﬁrst three in the list—thus
there is no direct relationship between rank order and T cell
responses, in accordance with the results shown with ZnT8
and (iii) epitopes predicted to bind weakly and which had
a poor sequence motif, induced T cell responses, such as
the epitope included in peptides 126–140, ranked in 243 in
Herman et al. (28), and peptides 121–140 and 231–250,
Fig. 1. The ﬁgures by WebLogo indicate the alignment of the naturally processed peptides of (A) HLA-DQ8 molecules and those of (B) I-A
g7
molecules. (C) The panels show the various residues associated with the HLA-DQ8 MHC-binding pockets; that is P1, P4, P6, P7 and P9,
including in panel (D), the LOD scores at P10 and P11. Those residues with positive scores are favorable and those with negative scores are
unfavorable. (E) The computational hindering residues of the HLA-DQ8 molecules. The statistical hindering residues are in gray and the structural
hindering residues are in vertical strip.
708 Prediction of HLA-DQ8 peptidomeranked 74 and 50, respectively, in Liu et al. (29). (Table 2
includes the 9-residue core identiﬁed by TEA-DQ8 in the
three segments.)
IA-2. Peptides from the cytoplasmic region of IA-2 were ex-
amined in a study by Kudva et al. (33). Each transgenic
DQ8 mouse was immunized with one of 25 peptides, each
of 18 residues in length: the T cell response was tested 10
days later. These 18-mer peptides spanned across the cyto-
plasmic region of IA-2 and each peptide overlapped adja-
cent peptides by three residues. Of the nine peptides that
induced a T cell response, seven were among the top 20
peptides ranked by TEA-DQ8 scanning the entire IA-2 pro-
tein. However, in agreement with the GAD65 results, two of
them ranked 29 and 70, also induced T cell responses, de-
spite having very poor binding motifs. Likewise, of the 16
peptides that did not induce a response, four were among
the top 20, including three that were ranked 1, 4 and 9 and
which contained an excellent binding motif. The remaining
12 were ranked <20 (Table 3).
Insulin. In the human pre-proinsulin, the transgenic DQ8
mice were injected with peptide and tested a week later
(34). These peptides which spanned across pre-proinsulin
were 20 amino acids in length overlapping adjacent pepti-
des by 10 residues. This experiment was designed to test
all possible binding registers although the precise 9-mer
segments were not identiﬁed. Out of 10 peptides, six stimu-
lated a T cell response and were associated with higher
LOD scores (Table 4).
Other proteins. Examined in NOD.DQ8 mice, the oral re-
sponse to gliadin resulted in response to only two peptides
out of 26 that were tested (36). These two peptides were
ranked 1 and 11 (Supplementary Table 2, available at Inter-
national Immunology Online). However, along the lines of
the results discussed above, a number of other peptides
ranked high, which showed excellent core sequences, were
negative. For one example, peptides 147–155: QSTYQLLQE,
ranked as 13. In another study, immunization with a number
of peptides from the house dust mites allergen P2 elicited
T cell responses including one which had a poor sequence
motif and was ranked 33 (peptides 102–110: ENVVVKVYTV,
LOD score of 0.67) (42). Again a number of peptides with
excellent core sequences, failed to stimulate T cell
responses. For example, peptides 105–113: VVTVKVMGD,
ranked as 10 having a LOD score of 0.33. Two other studies
also from David’s laboratory echoed these same results (43,
44) (data not discussed).
There were no obvious differences in sequences between
peptides that generated a T cell response and those that
failed, when considering all peptides in the database. (The
database has 78 peptides with P9 glutamic acid or aspartic
acid among those that did not stimulate T cells, compared
with 43 among those that did stimulate; other peptides with
non-acidic residues at P9 represented a minority but still did
not show any differences.) Whether in the two groups there
was a preferential association with other residues was also
examined. The group that stimulated T cells showed a slight
Table 1. The binding registers of ZnT8 of DQ8 class II MHC molecules
Sequence segment LOD scores TEA-DQ8 rank IC50 (lM) T cell response RankPep rank MHC2Pred rank
345–358 LTIQIESAADQDPS 1.63 1 2.5  30 51
330–343 RTGIAQALSSFDLH 1.27 2 2.5  20 26
166–179 LYPDYQIQAGIMIT 1.12 3 0.7 +++ 218 251
313–326 ILSVHVATAASQDS 1.03 5 4.9  46 2
128–141 SKRLTFGWYRAEIL 0.29 19 20.2  50 76
98–111 AILTDAAHLLIDLT 0.24 23 7.2  62 39
57–70 KATGNRSSKQAHAK 0.19 26 NB  19 168
292–305 AVDGVISVHSLHIW 0.13 30 18.0  119 20
NB, non-binder.
Fig. 2. The T cell responses to the ZnT8 peptides in NOD.DQ8 mice
measured in the IL-2 ELISPOT assay. (A) The T cell responses to the
ZnT8 peptides which bind weakly to the DQ8 molecules. (B) The
panel includes the T cell responses to the ZnT8 peptides which bind
stronger better than those included in (A).
Prediction of HLA-DQ8 peptidome 709preference for proline in the P1 to P8 segment, ;8.8%, com-
pared with 3.7% in the group that did not stimulate T cells.
Particularly at P6, the former showed a preference for ala-
nine, proline and valine: 48.8% versus 25.6%. Clearly, the
numbers are too small to point to a signiﬁcant relationship,
but these are recorded in Supplementary Figure 1 (available
at International Immunology Online).
Finally, TEA-DQ8 outperformed two of the public programs
(Table 1 and data not shown). Neither RankPep nor
MHC2Pep identiﬁed any of the peptides that induced a Tcell
response in the ZnT8 or GAD65.
Discussion
We presented a computational model for predicting the DQ8
peptidome and applied it to the identiﬁcation of the b cell-
DQ8 peptidome. A computational program that identiﬁes
the b cell-DQ8 peptidome will facilitate the discovery of
novel T cell epitopes in T1DM: it will be practically impossi-
ble to identify the b cell-DQ8 peptidome (or the b cell-I-A
g7
peptidome) by sampling natural peptides from the islets.
Presentation of b cell class II epitopes is by way of cell
transfer since the b cells do not express class II molecules.
Moreover, the number of APC within islets is very limited. In
the mouse system, we are testing insulinomas that are made
to express class II molecules but with a modest degree of
success (45).
The main characteristics of the program included applying
a specialized EM algorithm that aligned the DQ8 naturally
processed peptides based on their MHC-binding pockets,
determined computationally the hindering residues of DQ8
molecules and utilized the LOD scores with a baseline pro-
teome. We had reported a program to identify I-A
g7 pepti-
dome (24), which as indicated previously has some
differences from DQ8 peptidome, particularly at P1 and P4.
One advantage is that the program was based on peptides
Table 2. The DQ8 T cell epitope prediction on human
GAD65
a
Rank Segments LOD
scores
T cell
response
1 403–411 QCSALLVRE 1.41 
2 484–492 IIKNREGYE 1.19 
3 308–316 GKMIPSDLE 1.13 
4 464–472 TTGFEAHVD 1.09 +
5 385–393 ERANSVTWN 0.99 
6 297–305 DSVILIKCD 0.97 
7 140–148 ELLQEYNWE 0.93 
8 49–57 YGDAEKPAE 0.93 
9 571–579 IDFLIEEIE 0.88 
10 560–568 VISNPAATH 0.85 
11 430–438 DKHYDLSYD 0.83 
12 253–261 IARFKMFPE 0.80 
13 540–548 YGTTMVSYQ 0.79 +
14 433–441 YDLSYDTGD 0.72 +
15 316–324 ERRILEAKQ 0.66 
16 68–76 ARKAACACD 0.61 
17 512–520 SLRTLEDNE 0.60 
18 509–517 IPPSLRTLE 0.60 
19 481–489 LYNIIKNRE 0.55 +
20 466–474 GFEAHVDKC 0.54 
21 218–226 YVTLKKMRE 0.53 
22 209–217 IAPVFVLLE 0.52 +
23 94–102 ATDLLPACD 0.48 
24 256–264 FKMFPEVKE 0.47 
25 104–112 ERPTLAFLQ 0.46 +
26 570–578 DIDFLIEEI 0.46 
27 144–152 EYNWELADQ 0.45 
28 15–23 DGSGDSENP 0.41 
29 243–251 GAISNMYAM 0.40 
30 14–22 EDGSGDSEN 0.40 
50 240–248 SPGGAISNM 0.15 +
74 126–134 FDRSTKVID 0.07 +
243 128–136 RSTKVIDFH 1.51 +
aIn the study of Herman et al. (28), the examined peptide segments
were 15 amino acids long overlapped adjacent peptides by 10 amino
acids. Six epitopes were identiﬁed. In addition, their truncation
analysis revealed the minimal binding registers required to stimulate
Tcell responses. These six epitopes are 101–115 (104–112), 126–140
(127–136), 206–220 (208–217), 431–445, 461–475 and 536–550
(539–548), where the minimal epitopes are indicated inside the
parentheses. In the study of Liu et al. (29), the examined segments
were 20 amino acids long also overlapped by 10 amino acids. Four
epitopes were identiﬁed: 121–140, 201–220, 231–250 and 471–490.
bThe predicted binding registers matched the minimal epitopes
identiﬁed by the truncation analysis.
Table 3. The HLA-DQ8 T cell epitope prediction on IA-2 by
TEA-DQ8
a
Peptide examined TEA-DQ8
Segment T cell
response
Segment LOD Rank
931–948 + 935–943 EIDIAATLE 1.96 2
721–738 + 724–732 NTCATAQGE 1.58 5
722–730 EPNTCATAQ 0.72 14
601–618 + 610–618 ERLAALGPE 1.53 8
602–610 QHARQQDKE 0.48 20
826–843 + 835–843 YEVNLVSEH 1.11 10
828–836 GASLYHVYE 0.34 28
961–979 + 961–969 FALTAVAEE 0.94 11
616–633 + 619–627 GAHGDTTFE 0.91 12
622–630 GDTTFEYQD 0.60 17
661–678 + 664–672 AAQASPSSH 0.57 18
646–663 + 652–660 SRVSSVSSQ 0.34 29
766–783 + 868–876 TQFHFLSWP 0.31 70
676–693  680–688 EEPAQANMD 1.98 1
691–708  692–700 GHMILAYME 1.66 4
694–702 MILAYMEDH 0.48 22
706–723  714–722 QALCAYQAE 1.19 9
712–720 EWQALCAYQ 0.65 16
946–963  952–960 LVRSKDQFE 0.76 13
811–828  813–821 VEDGVKQCD 0.48 21
916–933  919–927 YILIDMVLN 0.43 23
796–813  800–808 ESGCTVIVM 0.39 26
856–873  716–724 LCAYQAEPN 0.38 27
863–871 ETRTLTQFH 0.41 24
751–768  755–763 VESSPSRSD 0.32 30
781–798  785–793 GPLSHTIAD 0.31 32
631–648  640–648 SLFNRAEGP 0.22 35
736–753  740–748 HPDFLPYDH 0.18 38
871–888  871–879 HFLSWPAEG 0.18 39
886–903  889–897 DFRRKVNKC 0.24 64
901–918  908–916 HCSDGAGRT 0.52 89
841–858  850–858 LVRSFYLKN 0.61 99
aTwenty-ﬁve peptides of IA-2 were tested on the DQ8 transgenic mice
in the study of Kudva et al. (33): nine out of these 25 peptides
stimulated Tcell responses. The table includes the top 30 predictions
by TEA-DQ8. The peptides ranked 3, 6, 7, 15, 19 and 25 were
excluded because those were not experimentally tested.
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libraries or phage display libraries in which the peptides are
not edited by the processing process. The nature of pepti-
des in the former differs from those in the latter (45).
Several conclusions became apparent as the program
was applied to the b cell proteins and for re-evaluating the
published results of others. TEA-DQ8 distinguished the pep-
tide binders of DQ8 molecules as indicated in the examina-
tion of ZnT8: the peptides with high LOD scores bound
better than those with low LOD scores. Similar results were
previously found with the peptides bound to I-A
g7. Using
mathematical proof based on the hypergeometric distribu-
tion, TEA-DQ8 performed signiﬁcantly better than random
guessing and it outperformed other programs that predict
DQ8 epitopes.
Although TEA-DQ8 identiﬁes correctly peptides that bind
to DQ8, predicting those that are the targets of T cell
responses is fraught with uncertainty. As a generalization,
the program identiﬁed immunogenic peptides that induced
T cell responses, but these were not ranked best in all exam-
ples. However, the lack of absolute relationship between the
rank order and the LOD scores and the presence or extent
of the T cell responses is very evident with the four examined
b cell antigens. Many peptide segments predicted to bind
well and which, indeed, showed the favorable binding
motifs, did not elicit T cell responses. In contrast, some poor
binding peptides were immunogenic.
Three explanations can be offered for interpreting these
results: ﬁrst, an epitope may have an excellent binding se-
quence but the segment of the protein is not appropriately
selected for processing; that is, the peptide is poorly dis-
played or not at all. When examining the natural peptides
selected by class II molecules, we commented previously
that the display and selection of peptides did not equate
necessarily to their binding afﬁnity (10, 13). Peptide selec-
tion from antigen processing depends on other factors that
are beyond having a class II MHC peptide-binding motif.
Clearly, several factors can come into play. Conditions that
should inﬂuence selection of peptides during antigen pro-
cessing include the extent of expression of the protein, the
localization in the cell, the susceptibility to proteolysis and
the presence or absence of interaction with auxiliary mole-
cules like HLA-DM. Thus, this is one major factor for the lack
of relationship between binding and degree of the T cell
response.
Second, the selection of T cells may depend on the avail-
ability of primary T cells to the peptide-MHC and/or to the
regulatory process that control the reactivity of the primary T
cell repertoire. In the experiments with ZnT8, IA-2 or insulin
discussed here, immunization was made with a library of
peptides so the issue of processing need not to be consid-
ered to explain the lack of T cell responses. The simplest
conclusion is that the functional T cell receptor repertoire is
limited to only a fraction of the MHC-presented peptides. In
the context of autoimmune proteins, some epitopes may be
very effective in inducing negative selection, while some
may not, depending on the factors described above includ-
ing the extent of expression in the thymus and the binding
afﬁnity to class II MHC molecules and on the interactions
with regulatory T cells.
Finally, another important feature with self-proteins is that
very weak class II-binding epitopes are effective in inducing
T cells (46). In the perspective of autoimmune diabetes, we
called attention to insulin peptides in NOD mice which in-
duce strong T cell responses but which bind weakly to the I-
A
g7 molecule (47, 48). Further examples were noted here
in the response to GAD65 and IA-2. Such weak-binding
peptides will be difﬁcult to identify by any computational pro-
gram. Weak-binding peptides may evade negative selection
and become the predominant effector reaction.
The ideal computational program is the one that ﬁrst iden-
tiﬁes peptide segments that bind to the MHC, such as this
one described here, but second segregates the peptides in-
to those that favor or do not favor T cell responses; that is
assuming that differences among the two groups may exist.
The present information is limited for the second, but this will
be the goal in the future as more data become available.
Supplementary data
Supplementary data, Tables 1 and 2 and Figure 1 are avail-
able at International Immunology Online.
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Table 4. The HLA-DQ8 T cell epitope prediction on human
pre-proinsulin by TEA-DQ8
a
Peptide examined TEA-DQ8
Segment T cell
response
Segment LOD Rank
34–53 + 37–45 B13–B21 EALYLVCGE 1.15 1
94–110 + 98–106 A9–A17 SICSLYQLE 1.02 2
1–24 + 12–20 p1–p20 ALLALWGPD 0.71 3
74–93 + 75–83 C19–C27 GSLQPLALE 0.66 4
44–63 + 51–59 B27–C3 TPKTRREAE 0.50 6
14–33 + 21–29 p21–B5 PAAAFVNQH 0.28 8
20–28 p20–B4 DPAAAFVNQ 0.26 9
19–27 p19–B3 PDPAAAFVN 0.18 11
84–103  87–95 C31–A6 QKRGIVEQC 0.50 5
64–83  67–75 C11–19 ELGGGPGAG 0.30 7
54–73  57–65 C1–C9 EAEDLQVGQ 0.19 10
61–69 C5–C14 LQVGQVELG 0.01 12
24–43  29–37 B5–B13 HLCGSHLVE 0.12 13
aTen peptides of human pre-proinsulin were tested on the DQ8
transgenic mice in the study of Raju et al. (34): six out of these 10
peptides stimulated T cell responses; 34–53 of pre-proinsulin is the
same as B10–B29 of insulin. The study by Alleva et al. (35) showed
that DQ8 restricted T cells against B9–B23 existed in human.
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APC antigen-presenting cells
ELISPOT enzyme-linked immunosorbent spot
EM expectation-maximization
GAD65 glutamic acid decarboxylase-65
IA-2 protein tyrosine phosphatase insulinoma-associated
antigen-2
LOD log of odds
T1DM type I diabetes mellitus
ZnT8 Zinc transporter 8
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